title: Failure of anti-TNF therapy in TNF Receptor 1-Associated Periodic Syndrome (TRAPS).
authors.forename: S
authors.initials: S
authors.lastname: Jacobelli
authors.forename: M
authors.initials: M
authors.lastname: André
authors.forename: J-F
authors.initials: JF
authors.lastname: Alexandra
authors.forename: C
authors.initials: C
authors.lastname: Dodé
authors.forename: T
authors.initials: T
authors.lastname: Papo
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D000068800:Etanercept; D010505:Familial Mediterranean Fever / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D000069285:Infliximab; D008297:Male; D018124:Receptors, Tumor Necrosis Factor; D047888:Receptors, Tumor Necrosis Factor, Type I / Q000037:antagonists & inhibitors* / Q000378:metabolism; D017211:Treatment Failure
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D047888:Receptors, Tumor Necrosis Factor, Type I; D000069285:Infliximab; D000068800:Etanercept